Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model

Transplantation

Volumn 73, Issue 4, 2002, Pages 519-528

  Erdag, Gulsun ^a   Morgan, Jeffrey R ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; FEMALE; GESTATIONAL AGE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SCID MOUSE; SKIN GRAFT;

EID: 0037181097     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202270-00005     Document Type: Article

References (30)

1. Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlierstage embryos by interferon
2. Fetal allograft survival in immunocompetent recipients is age dependent and organ specific
3. Can fetal and newborn allografts survive in an immunocompetent host?
4. Proliferation, zonal maturation, and steroid production of fetal adrenal transplants in adrenalectomized rats
5. Analysis of survival of allogeneic fetal liver fragments in rats
6. The influence of combined trophic factors on the success of fetal pancreas grafts
7. Development of transplanted fetal bones: Differences between isografts and allografts in mice
8. The major histocompatibility complex
9. Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells
10. Evidence that the effector mechanism of skin allograft rejection is antigen-specific
11. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection
12. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse
13. Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin
14. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts
15. Expression of serologically detectable H-2 antigens on mid-gestation mouse embryonic tissues
16. MHC expression in nonlymphoid tissues of the developing embryo: Strongest class I or class II expression in separate populations of potential antigen-presenting cells in the skin, lung, gut, and inter-organ connective tissue
17. Major histocompatibility complex class II antigen (HLA-DR, DQ and DP) expression in human fetal skin
18. Human fetal pancreas - A potential source for transplantation
19. Growth and development of antigen-free grafts of fetal mouse intestine
20. Development of human fetal skin transplanted to the nude mouse
21. Dopa reaction of fetal melanocytes before and after skin transplantation on to nude mice
22. Antigen presentation
23. Ontogeny of Ia-positive and Thy-1-positive leukocytes of murine epidermis
24. + dendritic epidermal cells in the perinatal period
25. Major histocompatibility complex class II-fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses
26. + T cells mediate rejection of porcine xenografts
27. Antigen presentation in brain: Brain endothelial cells are poor stimulators of T-cell proliferation
28. + allogeneic vascular endothelium. Identification of accessory interactions
29. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection
30. Prolonged survival of rhesus fetal skin grafts on nonimmunosuppressed allogeneic hosts